Search Results - "Jockenhoevel, F."

Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia by Holtmann, G, Goebell, H, Jockenhoevel, F, Talley, N J

“…Background—Abnormal visceral mechanosensory and vagal function may play a role in the development of functional gastrointestinal disorders. Aims—To assess…”
Get full text

Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly by Chanson, P., Boerlin, V., Ajzenberg, C., Bachelot, Y., Benito, P., Bringer, J., Caron, P., Charbonnel, B., Cortet, C., Delemer, B., Escobar-Jiménez, F., Foubert, L., Gaztambide, S., Jockenhoevel, F., Kuhn, J. M., Leclere, J., Lorcy, Y., Perlemuter, L., Prestele, H., Roger, P., Rohmer, V., Santen, R., Sassolas, G., Scherbaum, W. A., Schopohl, J., Torres, E., Varela, C., Villamil, F., Webb, S. M.

“…BACKGROUND AND OBJECTIVE The most effective option for the medical treatment of patients with acromegaly is the use of somatostatin analogues. Long‐acting…”
Get full text

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men by Debruyne, Frans M.J., Behre, Hermann M., Roehrborn, Claus G., Maggi, Mario, Wu, Frederick C.W., Schröder, Fritz H., Jones, Thomas Hugh, Porst, Hartmut, Hackett, Geoffrey, Wheaton, Olivia A., Martin‐Morales, Antonio, Meuleman, Eric, Cunningham, Glenn R., Divan, Hozefa A., Rosen, Raymond C., Dohle, G., Arver, S., Lenzi, A., Stroberg, P., Maggio, M., Cruz, N., Balercia, G., Yassin, A., Reisman, C., Bassa, L., Pescatori, E., Martinez Salamanca, J.I., Romero Otero, J., Jockenhoevel, F.

“…Objectives To evaluate the effects of testosterone‐replacement therapy (TRT) on prostate health indicators in hypogonadal men, including rates of prostate…”
Get full text

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME) by Maggi, Mario, Wu, Frederick C W, Jones, Thomas H, Jackson, Graham, Behre, Hermann M, Hackett, Geoffrey, Martin-Morales, Antonio, Balercia, Giancarlo, Dobs, Adrian S, Arver, Stefan T E, Maggio, Marcello, Cunningham, Glenn R, Isidori, Andrea M, Quinton, Richard, Wheaton, Olivia A, Siami, Flora S, Rosen, Raymond C

“…The aim of this study was to assess cardiovascular (CV) safety of testosterone replacement therapy (TRT) in a large, diverse cohort of European men with…”
Get more information

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME) by Rosen, Raymond C., Wu, Frederick, Behre, Hermann M., Porst, Hartmut, Meuleman, Eric J.H., Maggi, Mario, Romero-Otero, Javier, Martinez-Salamanca, Juan I., Jones, Thomas Hugh, Debruyne, Frans M.J., Kurth, Karl-Heinz, Hackett, Geoff I., Quinton, Richard, Stroberg, Peter, Reisman, Yacov, Pescatori, Edoardo S., Morales, Antonio, Bassas, Lluis, Cruz, Natalio, Cunningham, Glenn R., Wheaton, Olivia A., Maggi, M., Behre, H.M., Meuleman, E., Dohle, G., Arver, S., Wu, F., Porst, H., Jones, T.H., Quinton, R., Lenzi, A., Bouloux, P.-M., Morales, A.M., Hackett, G., Stroberg, P., Maggio, M., Cruz, N., Balercia, G., Yassin, A., Reisman, C., Bassas, L., Pescatori, E., Salamanca, J.I. Martinez, Otero, J. Romero, Jockenhoevel, F., Debruyne, F.

“…The benefits and risks of long-term testosterone administration have been a topic of much scientific and regulatory interest in recent years. To assess…”
Get full text

Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism by Schubert, M., Minnemann, T., Hübler, D., Rouskova, D., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W., Jockenhövel, F.

“…In an open-label, randomized, prospective trial, we investigated pharmacokinetics and several efficacy and safety parameters of a novel, long-acting…”
Get full text

Complete atrioventricular block during lithium therapy within therapeutic range by Halboos, A, Jockenhövel, F

“…A 69-year-old man came to the emergency unit because of vertigo and presyncope. A bipolar disorder - known since an age of 15 years - has been treated with 2 ×…”
Get more information

Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men by Jockenhövel, F, Minnemann, T, Schubert, M, Freude, S, Hübler, D, Schumann, C, Christoph, A, Ernst, M

“…ObjectiveTo compare the effects of two treatment modalities of testosterone on sexual functioning and mood.DesignForty men were randomized to receive either…”
Get full text

The influence of relaxin on motility of human sperm in vitro by Neuwinger, J, Jockenhövel, F, Nieschlag, E

“…Sperm of healthy men were incubated in an IVF medium with relaxin at concentrations of 3, 30, 300 and 3000 ng ml-1. Immediately after addition of relaxin and…”
Get more information

The Current Status of Therapy for Symptomatic Late-Onset Hypogonadism with Transdermal Testosterone Gel by Ebert, T., Jockenhövel, F., Morales, A., Shabsigh, R.

“…For over 50 years, testosterone therapy has been used for the treatment of hypogonadism. In recent years, there has been an increase in the use of testosterone…”
Get full text

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism by Minnemann, T., Schubert, M., Freude, S., Hübler, D., Gouni-Berthold, I., Schumann, C., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W., Jockenhövel, F.

“…Objective : To assess the efficacy and safety of a novel long-acting im testosterone undecanoate (TU) formulation in comparison with testosterone enanthate…”
Get full text

Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism by Schubert, Markus, Bullmann, Catharina, Minnemann, Timo, Reiners, Christoph, Krone, Wilhelm, Jockenhövel, Friedrich

“…No randomized study exists comparing the effects of different modes of androgen substitution on bone mineral density (BMD). We performed a prospective,…”
Get more information

The Effect of Long-term Testosterone (testosterone-undecanoate)Replacement Therapy on Prostate Specific Antigen and Prostate Volume in Hypogonadal Men by Sommer, F., Schwarzer, U., Christoph, A., Schubert, M., Huebler, D., Oettel, M., Engelmann, U., Jockenhoevel, Y.

Get full text

Lack of correlation between cadmium in seminal plasma and fertility status of nonexposed individuals and two cadmium-exposed patients by Keck, Christoph, Bramkamp, Gernot, Behre, Hermann M, Müller, Cornelia, Jockenhövel, Friedrich, Nieschlag, Eberhard

“…Cadmium concentrations were determined in semen samples of 12 men with proven fertility (group I) and 44 normozoospermic patients (group II) as well as 118…”
Get full text

Testosterone and the metabolic syndrome by Schubert, M, Jockenhövel, F

“…Abdominal obesity as a key cardiovascular risk factor as well as metabolic syndrome and type 2 diabetes mellitus are associated with low testosterone levels…”
Get full text

Asymptomatic primary hyperparathyroidism. Treatment or observation? by Jockenhövel, F, Reinwein, D

Get more information

Diagnostic value of bioactive FSH in male infertility by Jockenhövel, F, Khan, S A, Nieschlag, E

“…Bioactive FSH and immunoreactive FSH were determined in 193 infertile men and in 23 men with proven fertility using the Sertoli cell aromatase bioassay for…”
Get more information

Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers by Daul, A, Elter-Schulz, M, Poller, U, Jockenhövel, F, Pönicke, K, Boomsma, F, Man in't Veld, A J, Schäfes, R F, Brodde, O E

“…Epinine (N-methyl-dopamine, the active metabolite of ibopamine), is a full agonist at dopamine (DA)-receptors and alpha- and beta-adrenoceptors. To study…”
Get full text

Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men by Jockenhövel, F, Bhasin, S, Steiner, B S, Rivier, J E, Vale, W W, Swerdloff, R S

“…To assess its gonadotropin-inhibiting potency in man, three different doses of a GnRH antagonist [( Ac-D2-Nal1,D4-Cl-Phe2, D3-Pal3,…”
Get more information

Testosteron und das metabolische Syndrom by Schubert, M., Jockenhövel, F.

“…Zusammenfassung Die zentrale Adipositas als wesentlicher kardiovaskulärer Risikofaktor wie auch das metabolische Syndrom und der Typ-2-Diabetes mellitus sind…”
Get full text